Clinical Trial Update: Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update exploring how to optimize dosing of piperacillin/tazobactam for hospital-acquired pneumonia in Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Nosocomial Pneumonia | Phase 2, Phase 3 | Status: UNKNOWN